Standard BioTools Akcija

Standard BioTools EV/OCF

Vrijednost EV/OCF (Vrednost preduzeća na operativni tok novca) od Standard BioTools (LAB) na dan 17. авг 2026. je -3,27. Prethodne godine, EV/OCF (Vrednost preduzeća na operativni tok novca) je bio -0,96 — promjena od 239,60% (niži).

EV/OCF

-3,27

YoY

239,60%

Zadnja ažuriranja:

EV/OCF (Vrednost preduzeća na operativni tok novca) od Standard BioTools je 2026 -3,27 . EV/OCF (Vrednost preduzeća na operativni tok novca) od Standard BioTools je bio 2025 -0,96 . Pad je time 239,60% niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

Standard BioTools Анализа акција

Šta radi Standard BioTools? Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Standard BioTools

EV/OCF (Vrednost preduzeća na operativni tok novca) kompanije Standard BioTools iznosi -3,27 u 2026. godini.

EV/OCF (Vrednost preduzeća na operativni tok novca) od Standard BioTools se promijenio sa -0,96 na -3,27, što predstavlja promjenu od 239,60%. Vrijednost je niži nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EV/OCF (Vrednost preduzeća na operativni tok novca) Standard BioTools od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EV/OCF poredi vrednost preduzeća sa operativnim tokom novca, mereći koliko investitori plaćaju po jedinici gotovine generisane iz poslovanja.

Da biste proverili EV/OCF (Vrednost preduzeća na operativni tok novca)'s, bitno je da ga uporedite sa konkurentima u istoj industriji i sektoru. Na Eulopoolu, možete pronaći direktna upoređivanja industrije za EV/OCF (Vrednost preduzeća na operativni tok novca).

Dobar varira u zavisnosti od industrije i faze razvoja preduzeća. Na Eulopoolu, možete porediti EV/OCF (Vrednost preduzeća na operativni tok novca)'s Standard BioTools sa sličnim preduzećima u sektoru i prosekom industrije da biste proverili da li je atraktivan.

Access this data via the Eulerpool API

Вредновање — Standard BioTools

Sve ključne metrike — Standard BioTools

Раст